These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 6424221)

  • 1. [Hemodilution and plasmapheresis in the therapy of hyperviscosity syndromes].
    Di Lollo F; Fazzini G; Avanzi G
    Ric Clin Lab; 1983; 13 Suppl 3():225-44. PubMed ID: 6424221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Classification and physiopathology of the hyperviscosity syndrome].
    Larcan A; Stoltz JF
    Journ Annu Diabetol Hotel Dieu; 1983; ():179-97. PubMed ID: 6358611
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood hyperviscosity syndromes. Classification and physiopathological understanding. Therapeutic deductions].
    Larcan A; Stoltz JF
    Ann Med Interne (Paris); 1983; 134(5):395-410. PubMed ID: 6360007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of blood hyperviscosity].
    Larcan A; Stoltz JF
    Bull Acad Natl Med; 1982 Mar; 166(3):375-82. PubMed ID: 6751484
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
    Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
    Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis and hyperviscosity syndrome].
    Corral Alonso M; Barbolla ML
    Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasmapheresis therapy of hyperviscosity syndromes].
    Kamanabroo D
    Internist (Berl); 1983 Jan; 24(1):39-42. PubMed ID: 6341280
    [No Abstract]   [Full Text] [Related]  

  • 9. Syndromes of hyperviscosity.
    Wells R
    N Engl J Med; 1970 Jul; 283(4):183-6. PubMed ID: 4987394
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperviscosity syndrome in Waldenström's macroglobulinemia.
    Krol TC; Wood WS
    Am Fam Physician; 1981 Aug; 24(2):187-9. PubMed ID: 6789661
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
    Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
    Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
    Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
    Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based focused review of management of hyperviscosity syndrome.
    Stone MJ; Bogen SA
    Blood; 2012 Mar; 119(10):2205-8. PubMed ID: 22147890
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemostatic therapy in a patient with acquired von Willebrand disease and Waldenström disease with plasmapheresis and DDAVP].
    Thies K; Budde U; Hellstern P
    Beitr Infusionsther; 1990; 26():179-82. PubMed ID: 1703824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperviscosity in plasma cell dyscrasias.
    Kwaan HC
    Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmapheresis and cold sensitivity of immunoglobulin molecules. II. A study of macroglobulinemia polyclonalis spuria and immune complex disease.
    Waldenström JG
    Acta Med Scand; 1984; 216(5):467-74. PubMed ID: 6240922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of hyperviscosity by apheresis.
    Zarkovic M; Kwaan HC
    Semin Thromb Hemost; 2003 Oct; 29(5):535-42. PubMed ID: 14631553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperviscosity retinopathy. A scientific approach to therapy.
    Grindle CF; Buskard NA; Newman DL
    Trans Ophthalmol Soc U K (1962); 1976 Jul; 96(2):216-9. PubMed ID: 827830
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic plasmapheresis--a new form of adjuvant treatment (author's transl)].
    Tilz GP; Teubl I; Kopplhuber C; Vollmann H; Lanzer G
    Med Klin; 1976 Nov; 71(45):1952-7. PubMed ID: 825711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.